{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:27:49Z","timestamp":1786523269698,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijrobp.2026.03.002","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:25:18Z","timestamp":1773332718000},"page":"147-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prophylactic Recombinant Human Thrombopoietin Prevents Cancer Therapy-Induced Thrombocytopenia During Concurrent Chemoradiation Therapy in Limited-Stage Small Cell Lung Cancer: A Prospective, Multicenter, Phase II Clinical Trial"],"prefix":"10.1016","volume":"126","author":[{"given":"Shijiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongling","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaojie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.03.002_bib0001","first-page":"363","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0002","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2165\/11594310-000000000-00000","article-title":"Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: Results from a retrospective hospital-based cohort study","volume":"34","author":"Ten Berg","year":"2011","journal-title":"Drug Saf"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0003","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.clinthera.2009.11.020","article-title":"Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: A descriptive study of a large outpatient oncology practice database, 2000\u20132007","volume":"31","author":"Wu","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0004","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1089\/ars.2013.5635","article-title":"Hematopoietic stem cell injury induced by ionizing radiation","volume":"20","author":"Shao","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0005","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2019.04.013","article-title":"Platinum single-agent vs. platinum-based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer: A meta-analysis of randomized controlled trials","volume":"154","author":"Ma","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0006","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(12)70139-0","article-title":"Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: A randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)","volume":"13","author":"Atagi","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0007","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature21706","article-title":"The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors","volume":"544","author":"Lefran\u00e7ais","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0008","doi-asserted-by":"crossref","first-page":"587","DOI":"10.17219\/acem\/62454","article-title":"Tolerance of combined radiochemotherapy in cervical cancer patients","volume":"26","author":"Izmaj\u0142owicz","year":"2017","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0009","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-5002(00)00240-3","article-title":"Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control","volume":"33","author":"Videtic","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-132-5-200003070-00005","article-title":"Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer","volume":"132","author":"Vadhan-Raj","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0011","first-page":"437","article-title":"[A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor]","volume":"26","author":"Bai","year":"2004","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0012","first-page":"397","article-title":"[The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia]","volume":"84","author":"Bai","year":"2004","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0013","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1083\/jcb.201304054","article-title":"The incredible journey: From megakaryocyte development to platelet formation","volume":"201","author":"Machlus","year":"2013","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0014","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.2003.08.003","article-title":"Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia","volume":"21","author":"Vadhan-Raj","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0015","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.7150\/jca.26690","article-title":"A randomized controlled study of rhTPO and rhIL-11 for the prophylactic treatment of chemotherapy-induced thrombocytopenia in non-small cell lung cancer","volume":"9","author":"Xu","year":"2018","journal-title":"J Cancer"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0016","article-title":"Retrospective cohort study for thrombocytopenia during concurrent chemoradiotherapy for rectal cancer","volume":"13","author":"Teng","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0017","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s12185-017-2319-9","article-title":"Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: A randomized, placebo-controlled phase 2 study","volume":"106","author":"Winer","year":"2017","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0018","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/cam4.326","article-title":"Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors: A randomized phase I study","volume":"4","author":"Winer","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0019","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3324\/haematol.2020.251900","article-title":"A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies","volume":"106","author":"Al-Samkari","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0020","first-page":"115","article-title":"Clinical observation on recombinant human thrombopoietin for treatment of concurrent chemoradiation-induced thrombocytopenia in solid tumor patients","volume":"10","author":"Chen","year":"2012","journal-title":"Oncol Prog"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0021","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241260985","article-title":"Hetrombopag for the management of chemotherapy-induced thrombocytopenia in patients with advanced solid tumors: A multicenter, randomized, double-blind, placebo-controlled, phase II study","volume":"16","author":"Qin","year":"2024","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.970978","article-title":"Avatrombopag for the treatment of thrombocytopenia induced by chemotherapy in patients with solid tumors: A multicenter, open-label, single-arm trial","volume":"13","author":"Cui","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0023","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12885-019-5354-5","article-title":"Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice","volume":"19","author":"Weycker","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0024","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1078155210380293","article-title":"Incidence and risk factors of clinically significant chemotherapy-induced thrombocytopenia in patients with solid tumors","volume":"17","author":"Hitron","year":"2011","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0025","first-page":"282","article-title":"Managing thrombocytopenia associated with cancer chemotherapy","volume":"29","author":"Kuter","year":"2015","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0026","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1200\/JCO.2002.12.071","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104","volume":"20","author":"Takada","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0027","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.1997.15.3.893","article-title":"Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: A randomized study","volume":"15","author":"Jeremic","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0028","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1200\/JCO.1997.15.8.2840","article-title":"Randomized trial of alternating versus sequential radiotherapy\/chemotherapy in limited-disease patients with small-cell lung cancer: A European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study","volume":"15","author":"Gregor","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0029","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/cncr.32586","article-title":"Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses","volume":"126","author":"Hu","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13014-017-0788-x","article-title":"Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer","volume":"12","author":"Zhang","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0031","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/annonc\/mdn354","article-title":"A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer","volume":"19","author":"Sculier","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0032","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(20)30742-7","article-title":"High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: An open-label, randomised, phase 2 trial","volume":"22","author":"Gr\u00f8nberg","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0033","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S2213-2600(24)00189-9","article-title":"High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: A multicentre, open-label, randomised, phase 3 trial","volume":"12","author":"Yu","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0034","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1080\/10428194.2018.1459605","article-title":"Recombinant human thrombopoietin (rh-TPO) for the prevention of severe thrombocytopenia induced by high-dose cytarabine: A prospective, randomized, self-controlled study","volume":"59","author":"Wang","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0035","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.5114\/aoms\/141134","article-title":"Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia","volume":"17","author":"Li","year":"2021","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0036","article-title":"Recombinant human thrombopoietin promotes hematopoietic reconstruction after severe whole body irradiation","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0037","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.stem.2012.10.012","article-title":"Thrombopoietin-increased DNA-PK-dependent DNA repair limits hematopoietic stem and progenitor cell mutagenesis in response to DNA damage","volume":"12","author":"de Laval","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0038","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1182\/blood-2013-07-515874","article-title":"Thrombopoietin promotes NHEJ DNA repair in hematopoietic stem cells through specific activation of Erk and NF-\u03baB pathways and their target, IEX-1","volume":"123","author":"de Laval","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2026.03.002_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257673","article-title":"Systematic literature review and meta-analysis on use of thrombopoietic agents for chemotherapy-induced thrombocytopenia","volume":"17","author":"Soff","year":"2022","journal-title":"PLoS One"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626004852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626004852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:35:35Z","timestamp":1786520135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626004852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0360301626004852"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.03.002","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic Recombinant Human Thrombopoietin Prevents Cancer Therapy-Induced Thrombocytopenia During Concurrent Chemoradiation Therapy in Limited-Stage Small Cell Lung Cancer: A Prospective, Multicenter, Phase II Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}